| Year |
Citation |
Score |
| 2023 |
Kulbe JR, Nguyen L, Le AA, Laird AE, Taffe MA, Nguyen JD, Fields JA. Nicotine, THC, and Dolutegravir Modulate E-Cigarette-Induced Changes in Addiction- and Inflammation-Associated Genes in Rat Brains and Astrocytes. Brain Sciences. 13. PMID 38002516 DOI: 10.3390/brainsci13111556 |
0.372 |
|
| 2023 |
Ellis RJ, Marquine MJ, Kaul M, Fields JA, Schlachetzki JCM. Publisher Correction: Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management. Nature Reviews. Neurology. PMID 37872259 DOI: 10.1038/s41582-023-00895-y |
0.325 |
|
| 2023 |
Ellis RJ, Marquine MJ, Kaul M, Fields JA, Schlachetzki JCM. Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management. Nature Reviews. Neurology. 19: 668-687. PMID 37816937 DOI: 10.1038/s41582-023-00879-y |
0.482 |
|
| 2023 |
Kulbe JR, Le AA, Mante M, Florio J, Laird AE, Swinton MK, Rissman RA, Fields JA. GP120 and tenofovir alafenamide alter cannabinoid receptor 1 expression in hippocampus of mice. Journal of Neurovirology. 29: 564-576. PMID 37801175 DOI: 10.1007/s13365-023-01155-x |
0.44 |
|
| 2023 |
Garces A, Martinez B, De La Garza R, Roy D, Vallee KA, Fields JA, Moore DJ, Rodrigo H, Roy U. Differential expression of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) in Alzheimer's disease and HIV-1 associated neurocognitive disorders. Scientific Reports. 13: 3276. PMID 36841839 DOI: 10.1038/s41598-022-27276-7 |
0.348 |
|
| 2022 |
Fields JA, Swinton M, Sundermann EE, Scrivens N, Vallee KJ, Moore DJ. Complement component 3 and complement factor H protein levels are altered in brain tissues from people with human immunodeficiency virus: A pilot study. Frontiers in Aging Neuroscience. 14: 981937. PMID 36118688 DOI: 10.3389/fnagi.2022.981937 |
0.313 |
|
| 2022 |
Solanky D, Fields JA, Iudicello JE, Ellis RJ, Franklin D, Clifford DB, Gelman BB, Marra CM, Morgello S, Rubin LH, Grant I, Heaton RK, Letendre SL, Mehta SR. Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid. Journal of Neurovirology. PMID 35157246 DOI: 10.1007/s13365-022-01052-9 |
0.424 |
|
| 2021 |
Swinton MK, Sundermann EE, Pedersen L, Nguyen JD, Grelotti DJ, Taffe MA, Iudicello JE, Fields JA. Alterations in Brain Cannabinoid Receptor Levels Are Associated with HIV-Associated Neurocognitive Disorders in the ART Era: Implications for Therapeutic Strategies Targeting the Endocannabinoid System. Viruses. 13. PMID 34578323 DOI: 10.3390/v13091742 |
0.416 |
|
| 2021 |
Han MM, Frizzi KE, Ellis RJ, Calcutt NA, Fields JA. Prevention of HIV-1 TAT Protein-Induced Peripheral Neuropathy and Mitochondrial Disruption by the Antimuscarinic Pirenzepine. Frontiers in Neurology. 12: 663373. PMID 34211430 DOI: 10.3389/fneur.2021.663373 |
0.485 |
|
| 2020 |
Ellis RJ, Moore DJ, Sundermann EE, Heaton RK, Mehta S, Hulgan T, Samuels D, Fields JA, Letendre SL. Nucleic acid oxidation is associated with biomarkers of neurodegeneration in CSF in people with HIV. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 33055205 DOI: 10.1212/NXI.0000000000000902 |
0.325 |
|
| 2020 |
Saloner R, Fields JA, Marcondes MCG, Iudicello JE, von Känel S, Cherner M, Letendre SL, Kaul M, Grant I. Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 32929575 DOI: 10.1007/S11481-020-09957-0 |
0.534 |
|
| 2020 |
Ellis RJ, Diaz M, Sacktor N, Marra C, Collier AC, Clifford DB, Calcutt N, Fields JA, Heaton RK, Letendre SL. Predictors of worsening neuropathy and neuropathic pain after 12 years in people with HIV. Annals of Clinical and Translational Neurology. PMID 32619341 DOI: 10.1002/Acn3.51097 |
0.404 |
|
| 2020 |
Canchi S, Swinton MK, Rissman RA, Fields JA. Transcriptomic analysis of brain tissues identifies a role for CCAAT enhancer binding protein β in HIV-associated neurocognitive disorder. Journal of Neuroinflammation. 17: 112. PMID 32276639 DOI: 10.1186/S12974-020-01781-W |
0.562 |
|
| 2020 |
Fields JA, Swinton MK, Soontornniyomkij B, Carson A, Achim CL. Beta amyloid levels in CSF of HIV-infected people vary by exposure to antiretroviral therapy. Aids (London, England). PMID 32073451 DOI: 10.1097/Qad.0000000000002506 |
0.476 |
|
| 2019 |
Fields JA, Swinton MK, Carson A, Soontornniyomkij B, Lindsay C, Han MM, Frizzi K, Sambhwani S, Murphy A, Achim CL, Ellis RJ, Calcutt NA. Tenofovir disoproxil fumarate induces peripheral neuropathy and alters inflammation and mitochondrial biogenesis in the brains of mice. Scientific Reports. 9: 17158. PMID 31748578 DOI: 10.1038/S41598-019-53466-X |
0.48 |
|
| 2019 |
Swinton MK, Carson A, Telese F, Sanchez AB, Soontornniyomkij B, Rad L, Batki I, Quintanilla B, Perez-Santiago J, Achim CL, Letendre S, Ellis RJ, Grant I, Murphy AN, Fields JA. Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia. Neurobiology of Disease. 104502. PMID 31238091 DOI: 10.1016/J.Nbd.2019.104502 |
0.46 |
|
| 2019 |
Fields JA, Ellis RJ. HIV in the cART era and the mitochondrial: immune interface in the CNS. International Review of Neurobiology. 145: 29-65. PMID 31208526 DOI: 10.1016/Bs.Irn.2019.04.003 |
0.544 |
|
| 2018 |
Fields JA, Spencer B, Swinton M, Qvale EM, Marquine MJ, Alexeeva A, Gough S, Soontornniyomkij B, Valera E, Masliah E, Achim CL, Desplats P. Alterations in brain TREM2 and Amyloid-β levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy. Journal of Neurochemistry. PMID 30152135 DOI: 10.1111/Jnc.14582 |
0.545 |
|
| 2018 |
Kim C, Spencer B, Rockenstein E, Yamakado H, Mante M, Adame A, Fields JA, Masliah D, Iba M, Lee HJ, Rissman RA, Lee SJ, Masliah E. Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation. Molecular Neurodegeneration. 13: 43. PMID 30092810 DOI: 10.1186/S13024-018-0276-2 |
0.318 |
|
| 2018 |
Kesby JP, Fields JA, Chang A, Coban H, Achim CL, Semenova S. Effects of HIV-1 TAT protein and methamphetamine exposure on visual discrimination and executive function in mice. Behavioural Brain Research. PMID 29709610 DOI: 10.1016/J.Bbr.2018.04.046 |
0.425 |
|
| 2018 |
Rozzi SJ, Avdoshina V, Fields JA, Mocchetti I. Human immunodeficiency virus Tat impairs mitochondrial fission in neurons. Cell Death Discovery. 4: 8. PMID 29531805 DOI: 10.1038/S41420-017-0013-6 |
0.516 |
|
| 2017 |
Thaney VE, Sanchez AB, Fields JA, Minassian A, Young JW, Maung R, Kaul M. Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research. Journal of Neurovirology. PMID 29075998 DOI: 10.1007/S13365-017-0584-2 |
0.548 |
|
| 2017 |
Rozzi SJ, Avdoshina V, Fields JA, Trejo M, Ton HT, Ahern GP, Mocchetti I. Human Immunodeficiency Virus Promotes Mitochondrial Toxicity. Neurotoxicity Research. PMID 28695547 DOI: 10.1007/S12640-017-9776-Z |
0.554 |
|
| 2017 |
Divakaruni AS, Wallace M, Buren C, Martyniuk K, Andreyev AY, Li E, Fields JA, Cordes T, Reynolds IJ, Bloodgood BL, Raymond LA, Metallo CM, Murphy AN. Inhibition of the mitochondrial pyruvate carrier protects from excitotoxic neuronal death. The Journal of Cell Biology. PMID 28254829 DOI: 10.1083/Jcb.201612067 |
0.337 |
|
| 2017 |
Fields JA, Metcalf J, Overk C, Adame A, Spencer B, Wrasidlo W, Florio J, Rockenstein E, He JJ, Masliah E. The anticancer drug sunitinib promotes autophagyand protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration. Journal of Neurovirology. PMID 28105557 DOI: 10.1007/S13365-016-0502-Z |
0.539 |
|
| 2017 |
Valera E, Spencer B, Fields JA, Trinh I, Adame A, Mante M, Rockenstein E, Desplats P, Masliah E. Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy. Acta Neuropathologica Communications. 5: 2. PMID 28057080 DOI: 10.1186/S40478-016-0409-1 |
0.307 |
|
| 2016 |
Fields JA, Overk C, Adame A, Florio J, Mante M, Pineda A, Desplats P, Rockenstein E, Achim C, Masliah E. Neuroprotective effects of the immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity. Journal of Neuroinflammation. 13: 120. PMID 27220536 DOI: 10.1186/S12974-016-0585-8 |
0.577 |
|
| 2016 |
Avdoshina V, Fields JA, Castellano P, Dedoni S, Palchik G, Trejo M, Adame A, Rockenstein E, Eugenin E, Masliah E, Mocchetti I. The HIV Protein gp120 Alters Mitochondrial Dynamics in Neurons. Neurotoxicity Research. PMID 26936603 DOI: 10.1007/S12640-016-9608-6 |
0.585 |
|
| 2015 |
Fields JA, Serger E, Campos S, Divakaruni AS, Kim C, Smith K, Trejo M, Adame A, Spencer B, Rockenstein E, Murphy AN, Ellis RJ, Letendre S, Grant I, Masliah E. HIV alters neuronal mitochondrial fission/fusion in the brain during HIV-associated neurocognitive disorders. Neurobiology of Disease. PMID 26611103 DOI: 10.1016/J.Nbd.2015.11.015 |
0.565 |
|
| 2015 |
Fields JA, Dumaop W, Crews L, Adame A, Spencer B, Metcalf J, He J, Rockenstein E, Masliah E. Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders. Current Hiv Research. 13: 43-54. PMID 25760044 DOI: 10.2174/1570162X13666150311164201 |
0.514 |
|
| 2015 |
Fields J, Dumaop W, Elueteri S, Campos S, Serger E, Trejo M, Kosberg K, Adame A, Spencer B, Rockenstein E, He JJ, Masliah E. HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disorders. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 1921-38. PMID 25653352 DOI: 10.1523/Jneurosci.3207-14.2015 |
0.577 |
|
| 2014 |
Fields J, Dumaop W, Langford TD, Rockenstein E, Masliah E. Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disorders. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 9: 102-16. PMID 24510686 DOI: 10.1007/S11481-013-9520-2 |
0.553 |
|
| 2014 |
Nuber S, Tadros D, Fields J, Overk CR, Ettle B, Kosberg K, Mante M, Rockenstein E, Trejo M, Masliah E. Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD. Acta Neuropathologica. 127: 477-94. PMID 24509835 DOI: 10.1007/S00401-014-1255-5 |
0.311 |
|
| 2013 |
Fields J, Dumaop W, Adame A, Ellis RJ, Letendre S, Grant I, Masliah E. Alterations in the levels of vesicular trafficking proteins involved in HIV replication in the brains and CSF of patients with HIV-associated neurocognitive disorders. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 1197-209. PMID 24292993 DOI: 10.1007/S11481-013-9511-3 |
0.537 |
|
| 2013 |
Fields J, Dumaop W, Rockenstein E, Mante M, Spencer B, Grant I, Ellis R, Letendre S, Patrick C, Adame A, Masliah E. Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer. Journal of Neurovirology. 19: 89-101. PMID 23341224 DOI: 10.1007/S13365-012-0145-7 |
0.512 |
|
| 2011 |
Fields J, Gardner-Mercer J, Borgmann K, Clark I, Ghorpade A. CCAAT/enhancer binding protein β expression is increased in the brain during HIV-1-infection and contributes to regulation of astrocyte tissue inhibitor of metalloproteinase-1. Journal of Neurochemistry. 118: 93-104. PMID 21281310 DOI: 10.1111/j.1471-4159.2011.07203.x |
0.437 |
|
| Show low-probability matches. |